×

What are you searching for?




Healthcare

4 Min read

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY

Published On 25 Aug 2020 12:31 PM


SHARE THIS ARTICLE  


According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to determine the safety and immunogenicity of Covishield on healthy Indian adults will be conducted.
As per the statement given by Prakash Kumar Sing....


Tags : Serum Institute of India, Covishield, SII, Oxford University, COVID-19 vaccine,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)